SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
96RNAI is essentially a flame out reconstituted with VC funds to follow a scientifmichael_f_murphy-9/12/2003
95i very much respect the pov of several of you. what's your opinion of RNAI abob zagorin-9/12/2003
94The field is attracting an incredible array of the very best. The best at makinscaram(o)uche-9/12/2003
93>>Nucleonics Malvern, Pa. Private Robert Towarnicki, president & CEO; tuck-9/11/2003
92Thomas, I'd suggest reading the pdf of the inaugural issue of GenomeWeb'tuck-9/11/2003
91This looks interesting. Anyone have a view as to the science/hype balance here?Thomas-9/11/2003
90Thanks Tuck, That is a big concern, no? Zoiks. What are the other responses thThomas-9/11/2003
89RNAi company list from the free issue. Alnylam Cambridge, Mass. Private John Mmichael_f_murphy-9/10/2003
88Meanwhile, if the recent licensing activity seemed to be clearing the IP murk, ttuck-9/10/2003
87[Off-target effects update] >>Nat Cell Biol. 2003 Sep;5(9):834-9. Epub 20tuck-9/10/2003
86RNAi News: Innovative Newsletter to Focus on RNA Interference, New Tool For Funcbob zagorin-9/10/2003
85A bit of extra color from GenomeWeb on the Sirna/Tuschl license . . . >&gtuck-9/10/2003
84More colour on the Merck deal - NEW YORK, Sept 9 (Reuters) - Merck & Co. Innigel bates-9/10/2003
83Invitrogen Bolsters Leading Position in RNAi Research Tuesday September 9, 7:02SemiBull-9/9/2003
82Press Release Source: Sirna Therapeutics, Inc. Sirna Therapeutics Licenses SeminBulbaMan-9/9/2003
81Merck forms pact with biotech on new genetic method Tuesday September 9, 8:28 amkeokalani'nui-9/9/2003
80Thanks for this comment Nigel-because of this I own both CBMX and ACTG!Madharry-9/5/2003
79More from Google Alerts, this time fighting words from Antisense Pharma: Cheers,Thomas-9/4/2003
78All, My Google Alert sirna filter returned the following hit which includes linkThomas-9/3/2003
77siRNA, Oligo-Based Therapeutics, Intellectual Property & Investment Outlook SemiBull-9/2/2003
76Here's the last GenomeWeb free RNAi Round-Up: >>RNAi Roundup: Ambion,tuck-9/2/2003
75Archiving the penultimate free RNAi Roundup from GenomeWeb; it is soon to be a stuck-8/23/2003
74Sirna Therapeutics Reports Second Quarter Financial Results Message 19211565SemiBull-8/14/2003
73Dharmacon Launches ON-TARGET(TM) siRNA to Further Enhance the Specificity of siRSemiBull-8/14/2003
72Genta to buy Salus - BERKELEY HEIGHTS, N.J., Aug. 14 /PRNewswire-FirstCall/ -- nigel bates-8/14/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News